The role of classical and non-classical HLA class I antigens in human tumors.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Seminars in Cancer Biology

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.semcancer.2012.03.003PMID 22465194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel insights into the molecular mechanisms of HLA class I abnormalities

  2012cited by this paper
• Targeting HLA class I expression to increase tumor immunogenicity.

  2012cited by this paper
• Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time.

  2012cited by this paper
• Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix

  2012cited by this paper
• Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genes

  2012cited by this paper
• Associations of human leukocyte antigen class II genotypes with human papillomavirus 18 infection and cervical intraepithelial neoplasia risk

  2012cited by this paper
• Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

  2011cited by this paper
• Association of IFN-γ Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell Lines

  2011cited by this paper
• Increased PRAME antigen-specific killing of malignant cell lines by low avidity CTL clones, following treatment with 5-Aza-2′-Deoxycytidine

  2011cited by this paper
• The role of the proteasome in the generation of MHC class I ligands and immune responses

  2011cited by this paper
• Strategies to counteract MHC-I defects in tumors.

  2011cited by this paper
• CD8+ T Cells: Foot Soldiers of the Immune System

  2011cited by this paper
• Insights into the processing of MHC class I ligands gained from the study of human tumor epitopes

  2011cited by this paper
• The tolerogenic molecule HLA-G.

  2011cited by this paper
• Post-proteasomal and proteasome-independent generation of MHC class I ligands.

  2011cited by this paper
• HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

  2011cited by this paper
• Regulatory T-cell depletion synergizes with gp96-mediated cellular responses and antitumor activity

  2011cited by this paper
• Immunotherapy of hepatocellular carcinoma: is there a place for regulatory T-lymphocyte depletion?

  2011cited by this paper
• Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17.

  2011cited by this paper
• Regulation of major histocompatibility complex class I molecule expression on cancer cells by amyloid precursor-like protein 2

  2011cited by this paper
• Expression of the nonclassical HLA-G and HLA-E molecules in laryngeal lesions as biomarkers of tumor invasiveness.

  2011cited by this paper
• HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer.

  2011cited by this paper
• Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells.

  2011cited by this paper
• Therapeutic vaccination for cancer immunotherapy: Antigen selection and clinical responses

  2011cited by this paper
• PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I‐binding peptides in vivo

  2011cited by this paper
• Towards a systems understanding of MHC class I and MHC class II antigen presentation

  2011cited by this paper
• Serum sHLA‐G levels: A useful indicator in distinguishing colorectal cancer from benign colorectal diseases

  2011cited by this paper
• MAGE-A1, MAGE-A3, and NY-ESO-1 can be upregulated on neuroblastoma cells to facilitate cytotoxic T lymphocyte-mediated tumor cell killing

  2011cited by this paper
• Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.

  2011cited by this paper
• Running the gauntlet: from peptide generation to antigen presentation by MHC class I.

  2011cited by this paper
• Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors

  2011cited by this paper
• Expression of immune‐modulatory molecules HLA‐G and HLA‐E by tumor cells in glioblastomas: An unexpected prognostic significance?

  2011cited by this paper
• The multiple roles of the CD8 coreceptor in T cell biology: opportunities for the selective modulation of self‐reactive cytotoxic T cells

  2011cited by this paper
• Human leukocyte antigen‐G expression is associated with a poor prognosis in patients with esophageal squamous cell carcinoma

  2011cited by this paper
• Altered HLA Class I and HLA-G Expression Is Associated with IL-10 Expression in Patients with Cervical Cancer

  2011cited by this paper
• Up-regulation of HLA-G expression in cervical premalignant and malignant lesions.

  2011cited by this paper
• Genomic revelations of a mutualism: the pea aphid and its obligate bacterial symbiont

  2011cited by this paper
• DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

  2011cited by this paper
• HLA-G regulators in cancer medicine: an outline of key requirements

  2011cited by this paper
• Camouflage and sabotage: tumor escape from the immune system

  2011cited by this paper
• T-Cell Immune Function in Tumor, Skin, and Peripheral Blood of Advanced Stage Melanoma Patients: Implications for Immunotherapy

  2011cited by this paper
• Immunotherapy eradicates metastases with reversible defects in MHC class I expression

  2011cited by this paper
• Human leukocyte antigen-G (HLA-G) as a marker for diagnosis, prognosis and tumor immune escape in human malignancies.

  2011cited by this paper
• HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia.

  2011cited by this paper
• A novel category of antigens enabling CTL immunity to tumor escape variants: Cinderella antigens

  2011cited by this paper
• Association of defective HLA-I expression with antigen processing machinery and their association with clinicopathological characteristics in Kazak patients with esophageal cancer.

  2011cited by this paper
• Human leukocyte antigen-G in cancer: are they clinically relevant?

  2011cited by this paper
• Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients

  2010cited by this paper
• Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals

  2010cited by this paper
• Immunotherapy of MHC class I-deficient tumors.

  2010cited by this paper
• “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: Implications for immunotherapy

  2010cited by this paper
• A Novel Mechanism of Soluble HLA-G Mediated Immune Modulation: Downregulation of T Cell Chemokine Receptor Expression and Impairment of Chemotaxis

  2010cited by this paper
• Immune evasion of microsatellite unstable colorectal cancers

  2010cited by this paper
• Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.

  2010cited by this paper
• Relationship between HLA class I antigen processing machinery component expression and the clinicopathologic characteristics of bladder carcinomas

  2010cited by this paper
• Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma.

  2010cited by this paper
• Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association

  2010cited by this paper
• Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.

  2010cited by this paper
• HLA-G Expression in Human Breast Cancer: Implications for Diagnosis and Prognosis, and Effect on Allocytotoxic Lymphocyte Response After Hormone Treatment In Vitro

  2010cited by this paper
• The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions

  2010cited by this paper
• HLA-E and HLA-G Expression in Classical HLA Class I-Negative Tumors Is of Prognostic Value for Clinical Outcome of Early Breast Cancer Patients

  2010cited by this paper
• Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin Expression*

  2010cited by this paper
• Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule.

  2010cited by this paper
• Hypermethylation of HLA class I gene is associated with HLA class I down-regulation in human gastric cancer.

  2010cited by this paper
• Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells.

  2010cited by this paper
• Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma.

  2010cited by this paper
• HLA-G and its relation to proliferation index in detection and monitoring breast cancer patients.

  2010cited by this paper
• HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells.

  2010cited by this paper
• Cancer esearch oenvironment and Immunology ctive Depletion of Foxp 3 + Regulatory T Cells roves Effective Therapeutic Vaccination R inst Established Melanoma

  2010cited by this paper
• Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.

  2010cited by this paper
• MHC class I antigen presentation: learning from viral evasion strategies

  2009cited by this paper
• Down‐regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells

  2009cited by this paper
• Adoptive cell therapy for the treatment of patients with metastatic melanoma.

  2009cited by this paper
• The peptide-loading complex – antigen translocation and MHC class I loading

  2009cited by this paper
• Immunohistochemical Studies of Trophoblastic Tumors

  2009cited by this paper
• Downregulation of HLA class I molecules in primary oral squamous cell carcinomas and cell lines.

  2009cited by this paper
• Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2‐Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy

  2009cited by this paper
• Alterations of HLA class I expression in human melanoma xenografts in immunodeficient mice occur frequently and are associated with higher tumorigenicity

  2009cited by this paper
• Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)

  2009cited by this paper
• Characterization of HLA-G expression in renal cell carcinoma.

  2009cited by this paper
• In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes.

  2009cited by this paper
• RREB-1 Is a Transcriptional Repressor of HLA-G1

  2009cited by this paper
• Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation

  2009cited by this paper
• Nitric oxide produces HLA‐G nitration and induces metalloprotease‐dependent shedding creating a tolerogenic milieu

  2009cited by this paper
• Molecular mechanisms of MHC class I abnormalities and APM components in human tumors

  2008cited by this paper
• Structural basis for NKG2A/CD94 recognition of HLA-E

  2008cited by this paper
• Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells

  2008cited by this paper
• Epigenetic enhancement of antigen processing and presentation promotes immune recognition of tumors.

  2008cited by this paper
• Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations

  2008cited by this paper
• HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.

  2008cited by this paper
• HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

  2008cited by this paper
• Beyond the increasing complexity of the immunomodulatory HLA-G molecule.

  2008cited by this paper
• Activation of the JAK/STAT-1 Signaling Pathway by IFN-γ Can Down-Regulate Functional Expression of the MHC Class I-Related Neonatal Fc Receptor for IgG1

  2008cited by this paper
• Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancer.

  2008cited by this paper
• Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy

  2008cited by this paper
• The known unknowns of antigen processing and presentation

  2008cited by this paper
• Signaling defects in anti‐tumor T cells

  2008cited by this paper
• Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma

  2007cited by this paper
• Characterization of the immune escape phenotype of human gastric cancers with and without high‐frequency microsatellite instability

  2007cited by this paper
• Beta2‐microglobulin mutations in microsatellite unstable colorectal tumors

  2007cited by this paper

• LncRNA-CTD suppresses metastasis and immune evasion by modulating snail1 and MHC-I expression in colorectal cancer

  2025cites this paper
• Essential role of NLRC5 in cancer immune surveillance and cancer immunoediting

  2025cites this paper
• Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3)

  2025cites this paper
• Advances in cancer immunotherapy: historical perspectives, current developments, and future directions

  2025cites this paper
• Recent update on multi-epitope vaccine development for treating breast cancer

  2025cites this paper
• Association between human leukocyte antigen E expression and outcomes in solid tumors: a systematic review and meta-analysis

  2025cites this paper
• HOXA13 promotes immune evasion in bladder cancer by suppressing antigen processing and presentation, and phagosome pathways

  2025cites this paper
• The aryl hydrocarbon receptor is associated with monocytic AML and innate immune resistance reversible with an AHR inhibitor

  2025cites this paper
• CANNABIDIOL MODULATES CLASSICAL AND NON-CLASSICAL HLA EXPRESSION IN HUMAN CHORIOCARCINOMA CELL LINE

  2025cites this paper
• LATS1/2 loss promote tumor immune evasion in endometrial cancer through downregulating MHC-I expression

  2024cites this paper
• Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology.

  2024cites this paper
• Expression of Interleukin-13 Receptor Alpha 2 in Brainstem Gliomas

  2024cites this paper
• Integrative HLA typing of tumor and adjacent normal tissue can reveal insights into the tumor immune response

  2024cites this paper
• Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer

  2024cites this paper
• High Variability in HLA-DRB1*03, a Predisposing Allele in Acute Lymphoblastic Leukemia

  2024cites this paper
• Unleashing precision: a review of targeted approaches in pleural mesothelioma.

  2024cites this paper
• Unveiling Major Histocompatibility Complex-mediated Pan-Cancer Immune Features by Integrated Single-Cell and Bulk RNA Sequencing.

  2024cites this paper
• Assessment of cancer cell‐expressed HLA class I molecules and their immunopathological implications

  2024cites this paper
• Deciphering the role of alternative splicing in neoplastic diseases for immune-oncological therapies

  2024cites this paper
• Single-cell transcriptome profiling reveals cell type-specific variation and development in HLA expression of human skin.

  2024cites this paper
• Tumor mutational burden for the prediction of PD-(L)1 blockade efficacy in cancer: challenges and opportunities.

  2024cites this paper
• Combining Epigenetic and Immunotherapy in Cancer: Molecular Mechanisms

  2023cites this paper
• Transcriptome analysis of tertiary lymphoid structures (TLSs)-related genes reveals prognostic value and immunotherapeutic potential in cancer

  2023influential citation
• DeepHLAPred: a deep learning-based method for non-classical HLA binder prediction

  2023cites this paper
• The binding profile of SARS‐CoV‐2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion

  2023cites this paper
• Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota

  2023cites this paper
• Expression of the Non-classical HLA-E, -F, -G Molecules in the Tumour Microenvironment

  2023cites this paper
• Pervasiveness of HLA allele-specific expression loss across tumor types

  2023cites this paper
• 3'UTR-HLA-G polymorphisms and circulating sHLA-G are associated with breast cancer: Evidence from a meta-analysis.

  2022cites this paper
• Combination of Expanded Allogeneic NK Cells and T Cell-Based Immunotherapy Exert Enhanced Antitumor Effects

  2022cites this paper
• Cancer Immunology: Immune Escape of Tumors-Expression and Regulation of HLA Class I Molecules and Its Role in Immunotherapies.

  2022cites this paper
• Risk assessment of cancer patients based on HLA-I alleles, neobinders and expression of cytokines

  2022cites this paper
• Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities

  2022cites this paper
• Addressing CPI resistance in NSCLC: targeting TAM receptors to modulate the tumor microenvironment and future prospects

  2022cites this paper
• Cabozantinib in the treatment of patients with advanced renal cell carcinoma

  2022cites this paper
• What Inhibits Natural Killers’ Performance in Tumour

  2022cites this paper
• Flow Cytometry Analysis to Detect Lapatinib-Induced Modulation of Constitutive and IFN-γ-Induced HLA Class I Expression in HER2-Positive Breast Cancer Cells.

  2022cites this paper
• The theory of tumor ecosystem

  2022cites this paper
• HLA-G and the MHC Cusp Theory

  2022influential citation
• The Human Leukocyte Antigen G as an Immune Escape Mechanism and Novel Therapeutic Target in Urological Tumors

  2022cites this paper
• The Association of HLA-G Gene Polymorphism and Its Soluble Form With Male Infertility

  2022cites this paper
• Current Advance of Immune Evasion Mechanisms and Emerging Immunotherapies in Renal Cell Carcinoma

  2021cites this paper
• The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy

  2021influential citation
• Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies

  2021cites this paper
• Target-Based Radiosensitization Strategies: Concepts and Companion Animal Model Outlook

  2021cites this paper
• The role and mechanism of HLA complex group 11 in cancer.

  2021cites this paper
• HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine

  2021cites this paper
• Deregulation of HLA-I in cancer and its central importance for immunotherapy

  2021cites this paper
• Tumor infiltrating and peripheral CD4+ILT2+ T cells are a cytotoxic subset selectively inhibited by HLA-G in clear cell renal cell carcinoma patients.

  2021cites this paper
• Polymorphisms of Antigen-Presenting Machinery Genes in Non-Small Cell Lung Cancer: Different Impact on Disease Risk and Clinical Parameters in Smokers and Never-Smokers

  2021cites this paper
• Proteasome inhibitors restore the STAT1 pathway and enhance the expression of MHC class I on human colon cancer cells

  2021cites this paper
• Monospecific and Polyreactive Monoclonal Antibodies against Human Leukocyte Antigen-E: Diagnostic and Therapeutic Relevance

  2021cites this paper
• Relation human leukocyte antigen-A, B, DRB1 alleles and haplotypes with acute leukemia in the Iranian population

  2021cites this paper
• Chemotherapy agents stimulate dendritic cells against human colon cancer cells through upregulation of the transporter associated with antigen processing

  2021cites this paper
• Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation.

  2021cites this paper
• Relevance of 2′-O-Methylation and Pseudouridylation for the Malignant Melanoma

  2021cites this paper
• Cancer Immune Evasion Through Loss of MHC Class I Antigen Presentation

  2021cites this paper
• Tumor microenvironment immune response in pancreatic ductal adenocarcinoma patients treated with neoadjuvant therapy.

  2020influential citation
• Expression of HLA-G and its receptors in relation to transplant acceptance

  2020cites this paper
• The Potential of Soluble Human Leukocyte Antigen Molecules for Early Cancer Detection and Therapeutic Vaccine Design

  2020cites this paper
• KIR2DL4 genetic diversity in a Brazilian population sample: implications for transcription regulation and protein diversity in samples with different ancestry backgrounds

  2020cites this paper
• MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation.

  2020influential citation
• HLA allele-specific expression loss in tumors can shorten survival and hinder immunotherapy

  2020cites this paper
• Characterization of the expression and immunological impact of the transcriptional activator CREB in renal cell carcinoma

  2020cites this paper
• EZH2 inhibition: a promising strategy to prevent cancer immune editing.

  2020cites this paper
• The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis

  2020cites this paper
• Molecular mechanisms of human herpes viruses inferring with host immune surveillance

  2020cites this paper
• NLRC5: new cancer buster?

  2020cites this paper
• Targeting the coding sequence: opposing roles in regulating classical and non-classical MHC class I molecules by miR-16 and miR-744

  2020cites this paper
• Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation

  2020cites this paper
• Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patients

  2020cites this paper
• Long Non-coding RNAs: Emerging Roles in the Immunosuppressive Tumor Microenvironment

  2020cites this paper
• Editing the immunopeptidome of melanoma cells using a potent inhibitor of endoplasmic reticulum aminopeptidase 1 (ERAP1)

  2019cites this paper
• HLA‐G, HLA‐E, and IDO overexpression predicts a worse survival of Tunisian patients with vulvar squamous cell carcinoma

  2019cites this paper
• The Complex Nature of Soft Tissue Sarcomas, Including Retroperitoneal Sarcomas

  2019cites this paper
• Have Cells Harboring the HIV Reservoir Been Immunoedited?

  2019cites this paper
• Histone deacetylase inhibition up-regulates MHC class I to facilitate cytotoxic T lymphocyte-mediated tumor cell killing in glioma cells

  2019cites this paper
• In vitro education of human natural killer cells by KIR3DL1

  2019cites this paper
• The effects of mesenchymal stem cells on the IDO, HLA-G and PD-L1 expression of breast tumor cells MDA-MB-231 and MCF-7

  2019cites this paper
• The analysis of human leukocyte antigen‐G level in patients with endometrial cancer by Western blot technique

  2018cites this paper
• Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges

  2018cites this paper
• Targeted Therapies: Immunologic Effects and Potential Applications Outside of Cancer

  2018cites this paper
• Tumor immunotherapy—the potential of epigenetic drugs to overcome resistance

  2018cites this paper
• Kourami: graph-guided assembly for novel human leukocyte antigen allele discovery

  2018cites this paper
• Human leucocyte antigen‐G 14‐bp InDel polymorphism and oral squamous cell carcinoma risk in Chinese Han population: A case–control study

  2018cites this paper
• Molecular heterogeneity of prostate cancer bone metastasis

  2018cites this paper
• Generation of cancer vaccine immunogens derived from major histocompatibility complex (MHC) class I molecules using variable epitope libraries.

  2018cites this paper
• Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies

  2017cites this paper
• Antigen processing and immune regulation in the response to tumours

  2017cites this paper
• Epigenetics and immunotherapy: The current state of play

  2017cites this paper
• Immune selection during tumor checkpoint inhibition therapy paves way for NK-cell “missing self” recognition

  2017cites this paper
• DYNAMIC ASSESSMENT OF NK CELL INTERACTIONS WITH PEDIATRIC TUMOR CELLS TO PREDICT RESPONSE TO IMMUNOTHERAPY

  2017cites this paper
• Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors.

  2017cites this paper
• Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscape.

  2017cites this paper
• DNA vaccine encoding human papillomavirus antigens flanked by a signal peptide and a KDEL sequence induces a potent therapeutic antitumor effect

  2017influential citation
• Subgroups of Castration-resistant Prostate Cancer Bone Metastases Defined Through an Inverse Relationship Between Androgen Receptor Activity and Immune Response.

  2017cites this paper
• HLA class I expression predicts prognosis and therapeutic benefits from tyrosine kinase inhibitors in metastatic renal-cell carcinoma patients

  2017cites this paper
• Multiparametric immune profiling in HPV- oral squamous cell cancer.

  2017cites this paper
• The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms

  2017cites this paper
• HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance

  2017cites this paper